Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)
Clinical trial NCT05772169 · COMPLETED
Trial details
- NCT number
- NCT05772169
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-31
- Primary completion
- 2024-11-19
- Enrollment
- 1113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.